AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇳🇬

Glibenclamide in Nigeria

11 products registered with NAFDAC 11 active

Brand / ProductReg. No.HolderStatusExpires
Mecure's Glibenclamide Tablet_
Tablet
A11-100897Me Cure Industries Limitedactive24 Jun 2030
Glibenclamide Tablets**
Tablet
B4-8197Manfes Pharmaceutical Company Limitedactive20 Dec 2028
Hypo G 5 mg Tablet
Tablet
B4-6476Chanrai HealthCare Limitedactive24 May 2028
Glanil 5 mg Caplet (check pack size)
Caplet
04-2450Sygen Pharmaceuticals Limitedactive22 Feb 2028
Daovard Tablet**
Tablet
04-5944De - Godstime Industry Nig Ltdactive2 Aug 2026
Preffered Drugs' Glibenclamide Tablets
Tablet
B4-0923Preferred Drugs Nigeria Limitedactive28 Mar 2026
Glibenol Caplets
Caplet
04-2159Afrab-Chem Limitedactive28 Feb 2026
Bencoreg Tablet
Tablet
C4-1358Onifam Laboratories Limitedactive20 Dec 2025
Macnil Tablets
Tablet
C4-1430MacJay Pharmaceutical Co. Ltdactive20 Dec 2025
Daolife Tablet
Tablet
A4-4169Life - Line Pharmaceuticals Ltdactive20 Dec 2025
Diatab Tablet
Tablet
04-7837May & Baker Nigeria PLCactive27 Sept 2025

GlibenclamideNAFDAC Registration Details

NAFDAC (Nigeria) has 11 registered products containing Glibenclamide, of which 11 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.

Track Glibenclamide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.